Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue Sarcoma

3 Pogledi
administrator
administrator
07/18/23

Caitlin May, PhD, postdoctoral research fellowship at Eli Lilly and Company, discusses olaratumab's (Lartruvo) demonstrating anti-tumor activity in models of pediatric bone and soft-tissue sarcoma.

  • Kategorija

Prikaži više

0 Komentari Poredaj po

Nema komentara

Komentari na Facebooku

Sljedeći